Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer
Ontology highlight
ABSTRACT: This will be a randomized phase II clinical trial of patients with histologic documentation of metastatic colorectal cancer, who have received local and currently approved standard therapies, excluding RGF.
DISEASE(S): Colorectal Cancer,Colorectal Neoplasms
PROVIDER: 2180232 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA